Wuhan Zhongyuan Huadian Science & Technology
300018
FS Development Investment Holdings
300071
Shenzhen Crastal Technology
300824
Jiangsu Leadmicro Nano Technology
688147
Jiangsu Apon Medical Technology
300753
CN Stock MarketDetailed Quotes
001367 Zhejiang Haisen Pharmaceutical
- 30.16
- -0.03-0.10%
Pre-Opening Auction Dec 19 09:30 CST
3.10BMarket Cap25.87P/E (TTM)
0.00High0.00Low0lotVolume0.00Open30.19Pre Close0.00Turnover0.00%Turnover Ratio29.57P/E (Static)102.65MShares33.3152wk High2.33P/B788.82MFloat Cap17.6052wk Low33.21Limit Up26.15MShs Float59.68Historical High27.17Limit Down0.00%Amplitude17.60Historical Low0.34Dividend TTM--Avg Price0lotAsk1.12%Div YieldTTM100Lot Size0lotBid
Zhejiang Haisen Pharmaceutical Key Stats
EPS
According to the latest financial report of Zhejiang Haisen Pharmaceutical, the latest earnings per share (TTM) for the company is 0.86. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Zhejiang Haisen Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 12.95.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Zhejiang Haisen Pharmaceutical shows that the company's current ratio is 16.30, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Zhejiang Haisen Pharmaceutical, the quick ratio is 14.38, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Zhejiang Haisen Pharmaceutical? The latest ROE figure is 6.81%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Zhejiang Haisen Pharmaceutical, the total asset return on investment (ROA) is 6.35%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Zhejiang Haisen Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 41.37%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Zhejiang Haisen Pharmaceutical, the net profit margin is 27.17%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.